Autoimmune hepatitis is a rare autoimmune disease that causes inflammation in your liver. Without treatment, it can lead to serious health issues, like cirrhosis and liver failure. But with early diagnosis and treatment, you may go into remission. Many people manage the condition with medication and live longer lives.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Autoimmune hepatitis is a chronic liver disease that occurs when your immune system mistakenly attacks your liver cells. This leads to inflammation of your liver (hepatitis), which can cause serious damage over time.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Normally, your immune system makes and sends out antibodies to fight infections. But this condition is an autoimmune disease. That means your immune system attacks your healthy cells by mistake.
There’s no cure for autoimmune hepatitis. But long-term treatment can help reduce inflammation and prevent complications. Without treatment, the disease can worsen and lead to life-threatening health conditions, like cirrhosis and liver failure.
Autoimmune hepatitis is uncommon. Studies show it affects 10 to 50 out of every 100,000 people.
There are two main types of autoimmune hepatitis. The difference has to do with which type of antibodies your immune system produces:
Not everyone has symptoms with autoimmune hepatitis. You may not know you have it until a healthcare provider notices it on a lab test when they’re checking for other issues. Sometimes, symptoms develop later, after the disease starts to affect your liver function. If you do have symptoms, the first thing you may notice is how tired you feel (fatigue).
Advertisement
Other symptoms may include:
Researchers don’t know the exact cause of autoimmune hepatitis. But they know it’s an autoimmune disorder. These disorders occur when your immune system mistakes healthy cells as a threat. In autoimmune hepatitis, your immune system produces antibodies that target your liver cells.
Factors that may contribute to autoimmune hepatitis include:
No. Contagious viruses can cause viral hepatitis and spread. These include hepatitis A, B or C. Previous viral infections can trigger autoimmune hepatitis. But it isn’t a viral infection itself. It can’t spread to other people.
Studies suggest that more than 7 in 10 people with autoimmune hepatitis are female. It most commonly appears between the ages of 15 and 40.
Some people who develop the disease have a preexisting autoimmune disorder. These include:
If autoimmune hepatitis worsens, complications may include:
Your healthcare provider will ask about your symptoms, medical history and any other factors in your life that may cause liver issues. For example, they may ask about how much alcohol you drink. They may also want to review all the prescription and over-the-counter medications you take.
Your provider will also perform a physical exam, checking for signs of liver damage. These signs may include:
Your healthcare provider may refer you to a GI specialist or a liver doctor. This provider will use a combination of tests to make an autoimmune hepatitis diagnosis. These tests may include:
Advertisement
Your healthcare provider will treat autoimmune hepatitis with medications to suppress your immune system and protect your liver. These medications include corticosteroids and immunosuppressants.
Corticosteroids reduce inflammation. Your provider will start with a high dose to calm the inflammation in your body. Then, they’ll gradually lower your dose.
Providers prescribe a steroid called prednisone most often. It works well for most people, but it can have side effects. Other options — like budesonide — may have fewer. But it can’t be used in cirrhosis.
Immunosuppressants slow down or stop the autoimmune response in your body. Your provider may prescribe one with the steroid or after you’ve finished it. Common immunosuppressants are azathioprine and CellCept®.
As azathioprine has fewer side effects than steroids, it may work better for long-term maintenance therapy. You may need to take it on and off for life to keep your immune system from becoming overactive again.
The goal of the medications is to make the disease go into remission. That means that all symptoms and signs of the disease are gone. You may have to take the medications for several months to years before this happens.
When you’ve been in remission for at least two years, your healthcare provider may consider taking you off the immunosuppressant. But after you stop treatment, the disease can come back. This is called relapse. About half of all people who go into remission will have a relapse and need to start medication again.
Advertisement
Some people improve with medication, but not enough to go into remission. In this case, your provider may try different medications. Some people don’t respond at all, and the disease continues to worsen. If the disease becomes severe or you develop complications, you may need a liver transplant.
Untreated autoimmune hepatitis can lead to severe complications. Without treatment, about 50% of people die within five years. About 10% of people with untreated autoimmune hepatitis will be alive in 10 years.
With treatment, the prognosis is much better. After treatment, 91% of people with autoimmune hepatitis are alive in 10 years. After 20 years, 70% of people with the condition are still living.
Living with autoimmune hepatitis can feel overwhelming. But knowing your treatment options and working closely with your care team can help you feel more in control of your health. Staying informed and engaged in your care can make a real difference over time. While there’s no cure, treatment offers hope for the future.
Advertisement
Cleveland Clinic providers compassionately diagnose and treat all liver diseases using advanced therapies backed by the latest research.

Last reviewed on 11/03/2025.
Learn more about the Health Library and our editorial process.